PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for November 5, 2008 Subscribe to this News Feed    
 

InnoCielo Meridian Enterprise and FDA Module Selected By Genzyme

Genzyme implements BlueCielo's leading engineering content management solution

Rijswijk, The Netherlands (PRWEB) November 5, 2008 -- BlueCielo ECM Solutions, a leading global software company offering Engineering Content Management (ECM) solutions, announced today that Genzyme Corporation, one of the world's foremost biotechnology companies, has chosen BlueCielo to implement and validate its innovative ECM solution, InnoCielo Meridian Enterprise and the FDA Module, at four of the company's worldwide locations. These locations include Framingham, MA, USA; Suffolk, United Kingdom; Waterford, Ireland and Geel, Belgium. Genzyme continues to demonstrate its leadership by implementing sophisticated technology that will take it to new levels of efficiency and compliance. The FDA Module provides the technical controls related to compliance with 21 CFR Part 11 for their engineering drawings.

With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with 2007 revenues of $3.8 billion and 10,000 employees in locations spanning the globe.

"We continue to see a rapid adoption of the InnoCielo product suite in the biotechnology and pharmaceutical sectors," says Martijn Janmaat, BlueCielo's CEO. "Genzyme is a great example of the growing number of global life sciences companies that are bringing products to market faster by optimizing their processes in managing their critical engineering content. With efficient validation processes and the availability of accurate engineering information to the relevant people throughout the enterprise, companies are now much better able to manage and share all required good manufacturing practices (GMP) documentation and comply with the FDA's 21 CFR Part 11 regulation much more easily."

About BlueCielo ECM Solutions
BlueCielo ECM Solutions provides Engineering Content Management and Application Integration solutions for owner/operators in multiple vertical industries including energy, oil & gas, petrochemical, government, pharmaceutical, and discrete and process manufacturing. BlueCielo has more than two decades of industry experience with over 275,000 users in 50+ countries worldwide. The company has offices in the USA, UK, Russia, Germany and the Netherlands, together with an extensive global network of established partners. BlueCielo ensures a high level of service and support on a truly worldwide scale for its leading software solutions InnoCielo Meridian Enterprise, InnoCielo ImandrA for IBM FileNet P8 and InnoCielo TeamWork. For more information, please visit http://www.bluecieloecm.com, or call (800) 323 2926 ext 111 (toll-free from the USA), +1 404 634 3302 (Americas) or +31 (0)70 413 3700 (EMEA).

BlueCielo and InnoCielo are registered trademarks of BlueCielo ECM Solutions. All other brand names, product names, or trademarks belong to their respective holders. © 2008 BlueCielo ECM Solutions. All rights reserved.

###

Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Elise Tynan
BlueCielo ECM Solutions
+44 (0)7765 656571
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.